Adrenal Gland Flashcards
Causes of Cushing’s
Taking too many steroids
Pituitary dependent Cushing’s disease
Ectopic ACTH from lung cancer
adrenal adenoma secreting cortisol
Adrenal cortex tumour
Cushing’s investigation
24 h urine collection for urinary free cortisol
Blood diurnal cortisol levels
(cortisols usually highest at 9am and lowest at midnight, if asleep)
Dexamethasone - normal will suppress cortisol to zero, Cushing’s fail to suppress
Cushing’s medication
Excess cortisol
Inhibitors of steroid biosynthesis
metyrapone; ketoconazole
Conn’s treatment
Excess aldosterone
MR antagonist:
spironolactone, epleronone
Metyrapone mechanism
inhibition of 11b-hydroxylase
steroid synthesis in the zona fasciculata [and reticularis] is arrested at the 11-deoxycortisol stage
11-deoxycortisol has no negative feedback effect on the hypothalamus and pituitary gland.
Control Cushing’s before surgery for better recovery and after radiotherapy
Metyrapone side effects
Hypertension on long-term administration
Hirsutism
Ketoconazole mechanism
main use as an antifungal agent – although withdrawn in 2013 due to risk of hepatotoxicity
at higher concentrations, inhibits steroidogenesis – off-label use in Cushing’s syndrome
Block 17 alpha hydroxylase - inhibit cortisol production
Control Cushing’s prior to surgery
Ketoconazole side effects
Liver damage - possibly fatal - monitor liver function weekly, clinically and biochemically
Treatment of Cushing’s
Depends on cause
Pituitary surgery (transsphenoidal hypophysectomy)
Bilateral adrenalectomy
Unilateral adrenalectomy for adrenal mass
Conn’s syndrome
Benign adrenal cortical tumour (zona glomerulosa)
Aldosterone in excess
Hypertension and hypokalaemia
Conn’s syndrome : diagnosis
Primary hyperaldosteronism
Renin - angiotensin system should be suppressed (exclude secondary hyperaldosteronism)
Low renin and high aldosterone
Spironolactone mechanism
Converted to several active metabolites, including canrenone, a competitive antagonist of the mineralocorticoid receptor (MR).
Blocks Na+ resorption and K+ excretion in the kidney tubules (potassium sparing diuretic).
Orally active
Highly protein bound and metabolised in the liver
Spironolactone side effects
Menstrual irregularities (+ progesterone receptor) Gynaecomastia (- androgen receptor)
Epleronone
Also a mineralocorticoid receptor (MR) antagonist
Similar affinity to the MR compared to spironolactone
Less binding to androgen and progesterone receptors compared to spironolactone, so better tolerated
Phaeochromocytomas
These are tumours of the adrenal MEDULLA which secrete catecholamines - adrenaline and nor-adrenaline
Increased heart rate and hypertension
Holds adrenaline and then releases it all in one go